Medical device company Sensus Healthcare has introduced a new cloud-based platform, Sensus Cloud, that allows healthcare providers to monitor treatment progression, safeguard patient data and manage assets.
Built on an easy-to-navigate interface, the new platform provides a comprehensive management feature for assets and electronic medical records (EMR).
This allows users to collect real-time information from the device in order to manage multiple machines with Chat GPT.
As a result, the software will eliminate the need for manual data entry and allow automatic appointment scheduling and billing.
Sensus Cloud is designed to provide real-time status information about device use, number of patients treated, serums used, treatment types, service/maintenance information, system reporting/analytics, and patient images.
Sensus Healthcare chairman and CEO Joseph Sardano said: “The Sensus Cloud gives dermatologists and aesthetic practitioners unprecedented access to their patients’ records, streamlining the care they can provide.
“Its innovative integration of asset management, EMR capabilities, and AI data collection is unparalleled in the industry – empowering providers with an all-in-one platform for more efficient patient care.
“We are confident that Sensus Cloud will be an invaluable resource for dermatology providers looking to enhance their practice and provide better outcomes for patients.”
Furthermore, the platform provides optional predictive analytics to help healthcare providers predict potential issues as well as choose treatment options based on current patterns and trends.
It also allows healthcare providers to develop evidence-based protocols that will meet the needs and preferences of individual patients.
In order to provide an extra layer of security for the protection of user accounts, Sensus Cloud features multi-factor authentication. It also includes monitoring features to alert users to potential changes to data or assets.
Sensus Healthcare is set to demonstrate Sensus Cloud at the American Academy of Dermatology (AAD) Annual Meeting, which is scheduled from 17-19 March in New Orleans, US.